Stem Cell Therapy for Learning Disability

Abstract

Learning disabilities (LDs) are caused by genetic and/or neurological factors that alter brain functioning and affect processes related to learning, which include dyslexia, dysgraphia, and dyscalculia. It hinders the child’s academic, social, and overall life skills. Current treatments for LD include medication and rehabilitation, focusing on management of symptoms. Thus, there is a need to explore newer treatments which will work at cellular level. Stem cell therapy is an evolving field of regenerative medicine and has shown great potential as a treatment strategy for various neuro-developmental and neurological disorders. It addresses the core underlying pathology and its benefits are enhanced when combined with standard treatments. This chapter focuses on various aspects of stem cell therapy in LD which includes the basics of stem cell therapy, rationale for use of stem cells, mechanism of action, monitoring tools like PET CT scan, and multidisciplinary rehabilitation. We have also enumerated our clinical experience and results of patients who underwent autologous bone marrow mononuclear cell transplantation combined with extensive rehabilitation. These patients showed a positive outcome, without any major adverse events. Nineteen out of 20 patients showed improvement in reading, writing, mathematical skills, attention, memory, problem-solving, comprehension skills, spelling, vocabulary, and overall increased academic performance.

Combination of stem cell and repetitive transcranial magnetic stimulation in acute ischaemic stroke as a promising treatment: A case report

“…29,30 Furthermore, these results are consistent with existing studies in which stem cell therapy has been shown to enhance various abilities in patients with autism spectrum disorder or cerebral palsy, including comprehensive skills, attention, reading, writing, and memory capabilities. 31 Numerous studies investigating the application of stem cell therapy in stroke patients have yielded promising outcomes. A study conducted by Lee et al 20 showed that patients who received stem cell therapy displayed notable improvements in motor function, as assessed using the Fugl-Meyer assessment system, within a 90-day evaluation period.…”